Type to search

Moderna Files for Conditional Marketing Approval for its COVID-19 Vaccine in Adolescents in the European Union | Pharmtech Focus
Novartis Announces Iptacopan Met Phase II Study Primary Endpoint in Rare Kidney Disease IgA Nephropathy (IgAN) | Pharmtech Focus
Alternative to Oxford/AstraZeneca Now Available to Over 30s at Riverside Vaccination Centre | Pharmtech Focus